Brief Article Open Access
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 28, 2013; 19(16): 2543-2549
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2543
Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis
Sang Jung Park, Yeon Seok Seo, Soon Ho Um, Chang Ha Kim, Hyung Joon Yim, Jin Yong Jung, Bora Keum, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim, Ho Sang Ryu, Department of Internal Medicine, College of Medicine, Korea University, Seoul 136-705, South Korea
Jin Dong Kim, Department of Internal Medicine, Cheju Halla General Hospital, Jeju 690-766, South Korea
Beom Jin Park, Min Ju Kim, Department of Radiology, College of Medicine, Korea University, Seoul 136-705, South Korea
Soon Koo Baik, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Christian Hospital, Wonju 220-701, South Korea
Author contributions: Park SJ and Kim JD contributed equally to this work; Park SJ and Kim JD wrote the manuscript and participated in the statistical analysis; Seo YS, Yim HJ and Baik SK coordinated and supported the statistical analysis; Park BJ, Kim MJ, Kim CH and Jung JY collected all the data; Keum B, Jeen YT, Lee HS, Chun HJ, Kim CD and Ryu HS collected all the data, provided analytical tools and were involved in editing the manuscript; Um SH designed and coordinated the entire study, primarily edited the manuscript, and provided the financial support.
Supported by A Grant of the Korea Healthcare Technology R-D Project, Ministry of Health and Welfare, South Korea, No. A102065
Correspondence to: Soon Ho Um, MD, PhD, Department of Internal Medicine, College of Medicine, Korea University, No. 126-1 Anam-dong 5-ga, Seongbuk-gu, Seoul 136-705, South Korea. umsh@korea.ac.kr
Telephone: +82-2-9206608  Fax: +82-2-9531943
Received: October 22, 2012
Revised: February 19, 2013
Accepted: March 15, 2013
Published online: April 28, 2013
Processing time: 191 Days and 13 Hours

Abstract

AIM: To evaluate the significance of computed tomography (CT) findings in relation to liver chemistry and the clinical course of acute hepatitis.

METHODS: Four hundred and twelve patients with acute hepatitis who underwent enhanced CT scanning were enrolled retrospectively. Imaging findings were analyzed for the following variables: gallbladder wall thickness (GWT), arterial heterogeneity, periportal tracking, number and maximum size of lymph nodes, presence of ascites, and size of spleen. The serum levels of alanine aminotransferase, alkaline phosphatase, bilirubin, albumin, and prothrombin time were measured on the day of admission and CT scan, and laboratory data were evaluated every 2-4 d for all subjects during hospitalization.

RESULTS: The mean age of patients was 34.4 years, and the most common cause of hepatitis was hepatitis A virus (77.4%). The mean GWT was 5.2 mm. The number of patients who had findings of arterial heterogeneity, periportal tracking, lymph node enlargement > 7 mm, and ascites was 294 (80.1%), 348 (84.7%), 346 (84.5%), and 56 (13.6%), respectively. On multivariate logistic regression, male gender [odds ratio (OR) = 2.569, 95%CI: 1.477-4.469, P = 0.001], toxic hepatitis (OR = 3.531, 95%CI: 1.444-8.635, P = 0.006), level of albumin (OR = 2.154, 95%CI: 1.279-3.629, P = 0.004), and GWT (OR = 1.061, 95%CI: 1.015-1.110, P = 0.009) were independent predictive factors for severe hepatitis. The level of bilirubin (OR = 1.628, 95%CI: 1.331-1.991, P < 0.001) and GWT (OR = 1.172, 95%CI: 1.024-1.342, P = 0.021) were independent factors for prolonged cholestasis in multivariate analysis.

CONCLUSION: In patients with acute hepatitis, GWT on CT scan was an independent predictor of severe hepatitis and prolonged cholestasis.

Key Words: Acute hepatitis; Cholestasis; Computed tomography; Prognosis; Gallbladder

Core tip: Previous studies on the correlation between imaging and laboratory findings in acute hepatitis have shown conflicting results. This study revealed a correlation between abdominal computed tomography findings and liver biochemical parameters. In particular, gallbladder wall thickness (GWT) was the only independent imaging finding that predicts severe hepatitis and prolonged cholestasis. The results of this study suggest that GWT measurement, which is a relatively easy and objective procedure, is helpful to predict severe acute hepatitis or prolonged cholestasis.



INTRODUCTION

The principal causes of acute hepatitis include viral infection, use of certain drugs, heavy alcohol consumption, chemicals and autoimmunity. In laboratory testing, an increase in serum aminotransferase provides a basis for diagnosis; however, other tests may be conducted to determine the cause of disease and assess severity and prognosis. Abdominal ultrasonography and computed tomography (CT) may help to exclude other conditions that resemble acute hepatitis, such as biliary obstruction, cirrhosis, malignant metastasis to the liver, and diseases that alter liver biochemistry[1].

The general findings of abdominal ultrasonography in acute hepatitis include hepatomegaly, increased periportal echogenicity, decreased echogenicity in liver parenchyma and thickening of the gallbladder wall[2]. Computed tomography may also reveal lymphadenopathy around the hepatoduodenal ligament, fatty deposits around the liver, gallbladder changes, periportal tracking, hepatomegaly, splenomegaly and fluid retention within the pelvis in patients with acute hepatitis A[3].

The purpose of this study was to evaluate the significance of CT findings in relation to liver chemistry and the clinical course in patients with acute hepatitis.

MATERIALS AND METHODS
Patients

We conducted this study through a retrospective review of the medical records of 435 patients who had been hospitalized with acute hepatitis and examined with CT from January 2006 to May 2010. Patients who had previous chronic diseases, such as congestive heart failure, pulmonary diseases, chronic renal insufficiency, or uncontrolled diabetes mellitus, were not included. Twenty-three patients were also excluded because of a lack of relevant clinical chemistry findings or CT imaging obtained without contrast medium. The patients were treated with general symptomatic care with proper hydration and hepatotonic. The clinical and CT data of the 412 eligible patients were analyzed for this study. The cause of acute hepatitis was determined through obtaining a thorough medical history of alcohol consumption, drug use, and coexisting diseases, performing various serological and polymerase chain reaction (PCR) assays to diagnose a variety of viral, bacterial and protozoal infections of the liver caused by hepatitis viruses, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus, Toxoplasma, Leptospira, Candida, Mycobacteria, Brucella, pneumocystis, and if necessary, special biochemical tests for metabolic or hereditary hepatic diseases, including serum ceruloplasmin and 24-h urine copper quantification for Wilson’s disease. The institutional review board approved this study and waived the written informed consent requirement.

Laboratory examinations

The serum levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, albumin and prothrombin time (PT) were determined with a conventional autoanalyzer using commercial reagents on the day of admission and CT scan. These same examinations were repeated every 2-4 d for all subjects during hospitalization.

Diagnosis and definitions

The diagnosis of viral hepatitis was based on the positivity of hepatitis A virus, hepatitis B virus, or hepatitis C virus (HCV) markers. The laboratory criteria for confirming each type of acute hepatitis were as follows: acute hepatitis A, positive immunoglobulin M (IgM) antibody to hepatitis A virus; and acute hepatitis B, positive IgM antibody to hepatitis B core antigen and positive hepatitis B surface antigen with seroconversion at least 6 mo after initial presentation. Acute hepatitis C was considered to be present if the following criteria were met: an elevated serum ALT level with a documented normal level during the year before admission, no previous medical history of chronic hepatitis C, positive HCV RNA by PCR with known or suspected exposure to HCV within the preceding four months, and seroconversion of anti-HCV antibody[4,5]. Autoimmune hepatitis was diagnosed based on the recommendations of the International Autoimmune Hepatitis Group[6]. Toxic hepatitis (drug-induced liver injury) was confirmed in patients who had taken relevant various causative medications, herbs, or other xenobiotics within two months before admission and the aforementioned viral markers were all negative.

To identify a relationship between the severity of acute hepatitis and CT findings, we divided patients into two groups, one with and one without severe hepatitis (defined as serum bilirubin ≥ 10 mg/dL or PT ≤ 40% despite the administration of vitamin K in the most severe phase)[7,8]. To determine the factors associated with prolonged cholestasis, we arbitrarily divided patients into those with serum bilirubin ≥ 10 mg/dL for longer than 14 d and those having lower bilirubin levels or higher levels for less than 14 d.

Imaging

All examinations were performed with a 64-channel CT scanner (Brilliance 64, Phillips Medical Systems, Cleveland, OH, United States). The scanning parameters used were as follows: tube voltage, 120 kV; effective tube current, 200 mAs with dose modulation (D-Dom, Phillips Medical System); rotation time, 0.5 s; and collimation, 64 mm × 0.625 mm. In all patients, the abdominal CT was conducted with contrast enhancement. The delay between contrast medium administration and the commencement of scanning was determined individually for each patient using standard bolus-tracking software (Automatic Bolus Tracking, Phillips Medical Systems). Scanning began 7 s after a threshold attenuation of 300 HU was reached in the suprarenal aorta. For each patient, 100 mL of iomeprol (400 mg iodine per mL, Iomeron 400; Bracco, Milan, Italy) was injected into an antecubital vein. Contrast medium was injected monophasically at a rate of 3 mL/s. The portal venous and delayed phases started 75 and 120 s later, respectively.

Abdominal CT analysis

Two radiologists (Park BJ and Kim MJ, each with 10 years of experience in abdominal imaging) interpreted the CT images and reached an opinion by consensus. Both radiologists were blinded to the patient’s condition and blood test results. Six features of the CT image were interpreted (Figure 1): (1) gallbladder wall thickness (GWT) where the gallbladder is vertical to the surface of the liver in the part adjacent to the liver; (2) non-homogeneity of liver parenchyma in the arterial phase (arterial heterogeneity); (3) decreased attenuation along the portal vein, which is usually expressed as periportal tracking; (4) the maximum size and number of lymph nodes around the liver; (5) presence of ascites; and (6) size of the spleen.

Figure 1
Figure 1 Typical multi-channel computed tomography findings in patients with acute hepatitis. A: Gallbladder wall thickening (arrow); B: Arterial heterogeneity (asterisks), diffuse heterogeneous attenuation of liver parenchyma in the arterial phase; C: Periportal tracking (arrowheads), decreased attenuation, which highlights the portal vein; D: Lymphadenopathy (arrows) in portal hepatis. Other usual findings, e.g., ascites and splenomegaly, are not shown in this figure.
Statistical analysis

The results were presented as the mean ± SD or number of patients (%) as appropriate. The Mann-Whitney U test was used to compare groups of continuous data. Categorical data were evaluated using Fisher’s exact test or the χ2 test. Correlations between two continuous variables were assessed using linear regression analysis with the Spearman correlation coefficient. Multivariate analysis was conducted on variables with P < 0.1 in univariate analysis using logistic regression analysis to identify factors related to the severity of acute hepatitis or prolonged cholestasis. P values less than 0.05 were considered statistically significant. SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL, United States) was used for statistical analysis.

RESULTS
Baseline characteristics of the patients

The mean age (± SD) of 412 patients at the time of diagnosis was 34.4 (± 11.4) years (range, 11-92 years), and 237 (57.5%) were male. The most common cause of acute hepatitis was hepatitis A virus (n = 319, 77.4%). The other causes in order of frequency were toxicity, indeterminate, hepatitis B virus, alcoholism, HCV, and autoimmunity. Contrast-enhanced abdominal CT was performed at 1.5 d, on average, after admission (the second hospitalization day). The mean GWT on CT was 5.2 (± 5.5) mm, and 233 patients (56.5%) showed thickening of over 3 mm. The numbers of patients who showed arterial heterogeneity, periportal tracking, enlarged lymph nodes greater than 7 mm, and presence of ascites were 294 (80.1%), 348 (84.7%), 346 (84.5%), and 56 (13.6%), respectively. Spleen enlargement by greater than 12 cm was found in 95 patients (23.1%) (Table 1).

Table 1 Baseline characteristics of the patients n (%).
CharacteristicsTotal (n = 412)Severe hepatitis (n = 92)Non-severe hepatitis (n = 320)P valueProlonged cholestasis(n = 21)Non-prolonged cholestasis (n = 391)P value
Age1 (yr)34.4 ± 11.436.5 ± 11.533.8 ± 11.40.03542.6 ± 15.034.0 ± 11.10.013
Gender, male237 (57.5)62 (67.4)175 (54.7)0.03211 (52.4)226 (57.8)0.655
Etiology
Hepatitis A319 (77.4)67 (72.8)252 (78.8)8 (38.1)311 (79.5)
Toxic44 (10.7)17 (18.5)27 (8.4)10 (47.6)34 (8.7)
Unknown25 (6.1)1 (1.1)24 (7.5)0 (0)25 (6.4)
Hepatitis B16 (3.9)4 (4.3)12 (3.8)2 (9.5)14 (3.6)
Alcohol4 (1.0)1 (1.1)3 (0.9)0 (0)4 (1.0)
Hepatitis C2 (0.5)1 (1.1)1 (0.3)1 (4.8)1 (0.3)
Autoimmune2 (0.5)1 (1.1)1 (0.3)0 (0)2 (0.5)
Etiology, toxic44 (10.7)17 (18.5)27 (8.4)0.00110 (47.6)34 (8.7)< 0.001
ALT1 (IU/L)2053 ± 17592145 ± 22072027 ± 16110.392998 ± 10902110 ± 17720.001
ALP1 (IU/mL)155 ± 75152 ± 72156 ± 760.983153 ± 110156 ± 730.265
Bilirubin1 (mg/dL)5.6 ± 4.911.2 ± 6.73.9 ± 2.6< 0.00118.6 ± 6.94.9 ± 3.7< 0.001
Albumin1 (g/dL)3.9 ± 0.43.8 ± 0.44.0 ± 0.4< 0.0013.8 ± 0.43.9 ± 0.40.174
PT1 (%)81.0 ± 18.075.2 ± 22.783.7 ± 16.60.00384.6 ± 15.081.7 ± 18.60.721
GWT1, mm5.2 ± 5.57.2 ± 6.05.5 ± 5.30.0099.6 ± 6.75.7 ± 5.40.003
> 3233 (56.5)70 (70.7)168 (51.7)0.00417 (81.0)216 (55.2)0.025
> 7142 (34.5)36 (39.1)106 (33.1)0.04011 (52.4)131 (33.5)0.005
Arterial heterogeneity (+)294 (80.1)68 (73.9)226 (70.6)0.75515 (71.5)279 (71.3)1.000
Periportal tracking (+)348 (84.7)78 (84.8)270 (84.4)0.86918 (85.7)330 (84.4)1.000
LN number14.8 ± 3.05.1 ± 3.34.8 ± 2.90.5815.3 ± 3.74.8 ± 3.00.701
LN size1 (cm)0.97 ± 0.260.99 ± 0.280.96 ± 0.260.4650.97 ± 0.300.97 ± 0.260.743
≥ 0.8346 (84.5)79 (85.9)267 (83.4)0.63217 (81.0)329 (84.1)0.759
> 1162 (39.3)42 (45.7)120 (37.5)0.18310 (47.6)152 (38.9)0.494
Ascites (+)56 (13.6)17 (18.5)39 (12.2)0.1237 (33.3)49 (12.5)0.015
Spleen size1 (cm)10.9 ± 1.611.04 ± 1.6810.84 ± 1.600.41910.44 ± 1.710.91 ± 1.60.094
≥ 1295 (23.1)24 (26.1)71 (22.2)0.4833 (14.3)92 (23.5)0.431
Correlation between CT findings and liver chemistry

GWT was related to serum ALT (r = 0.234, P < 0.001), ALP (r = 0.180, P < 0.001), bilirubin (r = 0.319, P < 0.001), albumin (r = -0.282, P < 0.001), and PT (r = -0.118, P = 0.017). Lymph node size was correlated with serum ALT (r = 0.164, P = 0.001), ALP (r = 0.135, P = 0.006), and bilirubin (r = 0.138, P = 0.005). The number of lymph nodes was correlated with serum ALP (r = 0.150, P = 0.003) and bilirubin (r = 0.202, P < 0.001). The spleen size was correlated with serum ALT (r = 0.119, P = 0.015) and bilirubin (r = 0.190, P < 0.001). Serum ALT levels (P < 0.001) and PT (P = 0.032) varied depending on the presence of arterial heterogeneity. The presence of periportal tracking was related to serum ALP (P = 0.007), bilirubin (P < 0.001), and albumin (P = 0.002). The presence of ascites was related to serum ALT (P = 0.005), bilirubin (P = 0.012), and albumin (P < 0.001) levels and PT (P = 0.006) (Table 2).

Table 2 Relationship between computed tomography findings and liver chemistry (mean ± SD).
GWTLN maximum sizeLN numberSpleen sizeArterial heterogeneity
Periportal tracking
Ascites
Absence (n = 73)Presence (n = 294)P valueAbsence (n = 63)Presence (n = 348)P valueAbsence (n = 356)Presence (n = 56)P value
ALT(IU/L)0.234 (< 0.001)0.164 (0.001)-0.013 (0.798)0.119 (0.015)1504 ± 14782216 ± 1794< 0.0011994 ± 21392064 ± 16880.0741981 ± 17692509 ± 16410.005
ALP (IU/mL)0.180 (< 0.001)0.135 (0.006)0.150 (0.003)0.086 (0.082)145 ± 76159 ± 750.108133 ± 63159 ± 760.007154 ± 76164 ± 660.152
Bilirubin (mg/dL)0.319 (< 0.001)0.138 (0.005)0.202   (< 0.001)0.190 (< 0.001)5.6 ± 5.25.6 ± 4.90.4514.3 ± 5.15.8 ± 4.9< 0.0015.3 ± 4.77.0 ± 5.90.012
PT (s)-0.118 (0.017)-0.038 (0.445)0.072   (0.149)-0.092 (0.061)86 ± 1681 ± 180.03281 ± 2082 ± 180.79582 ± 1876 ± 170.006
Albumin (g/dL)-0.282 (< 0.001)-0.018 (0.717)-0.017 (0.739)-0.062 (0.206)4.0 ± 0.43.9 ± 0.40.4044.1 ± 0.43.9 ± 0.40.0024.0 ± 0.43.7 ± 0.4< 0.001
Factors associated with acute hepatitis severity

On univariate analysis, age, gender, frequency of toxic hepatitis, serum bilirubin and albumin, PT at the time of CT scanning and GWT showed significant differences (P < 0.05) between the group with severe hepatitis (defined as bilirubin ≥ 10 mg/dL or PT ≤ 40% in the most severe phase) and the group with non-severe hepatitis. On multivariate analysis, male gender [odds ratio (OR) = 2.569, 95%CI: 1.477-4.469, P = 0.001], toxic hepatitis (OR = 3.531, 95%CI: 1.444-8.635, P = 0.006), low serum albumin (OR = 2.154, 95%CI: 1.279-3.629, P = 0.004), and high GWT (OR = 1.061, 95%CI: 1.015-1.110, P = 0.009) independently predicted severe hepatitis (Tables 1 and 3).

Table 3 Multivariate logistic regression analysis for the factors associated with severe acute hepatitis and prolonged cholestasis in acute hepatitis.
VariablesOR95%CI for OR
P value
LowerUpper
Severe acute hepatitis
Age (yr)1.0070.9281.0330.579
Gender, male2.5691.4774.4690.001
Etiology, toxic3.5311.4448.6350.006
Albumin (g/dL)2.1541.2793.6290.004
GWT (mm)1.0611.0151.1100.009
Prolonged cholestasis in acute hepatitis
Age (yr)0.3930.0592.5990.333
Etiology, toxic6.8480.96048.8590.055
ALT (IU/L)1.0001.0001.0010.607
Bilirubin (mg/dL)1.6281.3311.991< 0.001
GWT (mm)1.1721.0241.3420.021
Ascites0.4840.1196.0390.869
Factors associated with prolonged cholestasis

Patient age, frequency of toxic hepatitis, serum ALT and bilirubin levels at the time of CT scan, GWT, and the frequency of ascites differed significantly between patients with prolonged cholestasis and those with non-prolonged cholestasis (Table 1). In this study, prolonged cholestasis was defined as serum bilirubin levels of 10 mg/dL or higher sustained for longer than 14 d. On multivariate analysis, elevated serum bilirubin (OR = 1.628, 95%CI: 1.331-1.991, P < 0.001) and increased GWT (OR = 1.172, 95%CI: 1.024-1.342, P = 0.021) were independently predictive for prolonged cholestasis. Three hundred and fifty-six of 357 patients with bilirubin levels less than 10 mg/dL at the time of CT scan were assigned to the non-prolonged cholestasis group. Among patients with serum bilirubin levels ≥ 10 mg/dL (n = 55), 79% (22/28) of patients with GWT less than 5 mm were classified in the non-prolonged cholestasis group, and 71% (5/7) of those with GWT of 13 mm or higher were classified in the prolonged cholestasis group (Tables 1 and 3).

DISCUSSION

Hepatomegaly, increased periportal echogenicity, decreased parenchymal echogenicity, lymph node enlargement, and a thickened gallbladder wall are frequently observed during the ultrasonographic examination of patients with acute hepatitis[2,9-12]. Similar findings also appear on CT scan[13-16], and CT easily detects lymphadenopathy and gallbladder wall thickening. The “periportal tracking” observed on CT may correspond to the same pathology as “increased periportal echogenicity” on ultrasonography. The non-homogeneity of liver parenchyma observed in the arterial phase of dynamic CT (arterial heterogeneity) is a CT-specific image generated by contrast media in patients with acute hepatitis[17]. These image findings are most commonly observed at the icteric phase of acute hepatitis[3].

Thickening of the gallbladder wall has attracted attention because it may be detected by ultrasonography in 51%-91% of patients with acute hepatitis[18-22]. In a recent study, ultrasonography within 7 d after symptomatic onset of acute hepatitis showed morphological changes in the gallbladder in more than 80% of patients, and these findings normalized as the hepatitis improved clinically[20]. In the present study, 56.6% of patients with acute hepatitis demonstrated an abnormal GWT when GWT > 3 mm was defined as abnormal. In addition, we observed other CT findings in patients with acute hepatitis, including lymph node enlargement, periportal tracking, and arterial heterogeneity at frequencies of 84.5%, 84.7% and 80.1%, respectively. These values were all higher than the frequency of GWT.

Correlations between imaging and laboratory findings in acute hepatitis have not been closely investigated. Studies on the correlation between GWT and the liver chemistry index show conflicting results. Some studies show that GWT increases at elevated serum aminotransferase levels[22,23], while other studies do not show this correlation[18,19,24]. Suk et al[24] showed a significant correlation between GWT and increases in serum bilirubin. In the present study, GWT clearly correlated with elevated serum bilirubin and liver enzymes, which supports the hypothesis that inflammation and necrosis in the liver parenchyma induce an inflammatory reaction and hyperemia in muscular and serosal layers of the gallbladder wall[23]. We also found a negative correlation between GWT and serum albumin levels, which suggests that hypoalbuminemia caused by acute hepatitis contributes to gallbladder wall edema. Patients with chronic renal insufficiency or cirrhosis who also have hypoalbuminemia frequently present gallbladder wall thickening[14].

In the present study, imaging findings other than GWT showed significant correlations with the serum levels of ALT, ALP, bilirubin, albumin and PT. These imaging findings included lymph node enlargement around the hepatoduodenal ligament, arterial heterogeneity, and periportal tracking. These correlations suggested that image findings may reflect liver damage and hepatic dysfunction, at least to some degree (Table 2). We therefore tested the prognostic value of imaging data in patients with acute hepatitis. First, we designated patients with serum bilirubin levels ≥ 10 mg/dL or PT index ≤ 40% despite the administration of vitamin K as having severe hepatitis, and we then sought to identify factors that may predict this outcome. In our analysis, male gender, toxic hepatitis, low serum albumin, and increased GWT independently predicted severe hepatitis. Furthermore, increased GWT and high serum bilirubin levels at the time of CT scanning independently predicted prolonged cholestasis. Because only approximately 20% of patients with hyperbilirubinemia (serum bilirubin > 10 mg/dL) at the time of CT scan showed prolonged cholestasis if their GWT was < 5 mm, the detection of GWT may be of value in predicting prolonged cholestasis in patients with acute hepatitis. Of course, other imaging modalities could substitute for CT scan unless CT is absolutely necessary, especially in young patients, to avoid unnecessary radiation exposure if they could also depict changes in the gallbladder, considering arguments on the safety of radiation exposure caused by CT scan in young patients[25,26].

This study is limited by its retrospective design. Therefore, we could not investigate the correlation between imaging findings and the duration of hospitalization because the criteria for patient discharge were not set in advance. Similarly, we could not determine the time of symptomatic onset of hepatitis in many patients. However, this study is strengthened by its size, which allowed us to confirm significant correlations between imaging findings and liver chemistry data in patients with acute hepatitis. In addition, this study revealed the value of GWT for predicting the outcome of acute hepatitis.

In conclusion, abdominal CT findings and liver biochemical parameters in patients with acute hepatitis showed some correlations, and GWT was the only imaging variable that independently predicted the severity of acute hepatitis or prolonged cholestasis.

COMMENTS
Background

In patients with suspected acute hepatitis, imaging studies, such as ultrasonography or computed tomography (CT), are usually performed to rule out other diseases presenting with similar clinical and biochemical abnormalities (e.g., extrahepatic cholestasis, diffuse metastatic disease or cirrhosis).

Research frontiers

Studies on the correlation between imaging and laboratory findings in acute hepatitis have shown conflicting results.

Innovations and breakthroughs

This large-scale study has revealed significant correlations between abdominal CT findings and liver biochemical parameters. Furthermore, gallbladder wall thickness (GWT), which can be easily measured by other imaging techniques as well, was found to be valuable for predicting the outcome of patients with acute hepatitis.

Applications

The results of this study suggest that GWT measurement by imaging modalities is helpful to classify patients with severe acute hepatitis or prolonged cholestasis.

Terminology

GWT refers to the thickness of the gallbladder wall vertical to the surface of the liver in the part adjacent to the liver.

Peer review

The authors describe the CT findings of severe acute hepatitis in 412 hospitalized patients. They found that GWT was an independent predictive factor for severe hepatitis. My main criticism is the relevance of such a paper. This study involved exposing young people to unnecessary radiation.

Footnotes

P- Reviewer Malnick SDH S- Editor Gou SX L- Editor A E- Editor Xiong L

References
1.  Aslam R, Sun Y, Yee J. Critical evaluation of the specificity and sensitivity of liver imaging. Zakim and Boyer’s hepatology: a textbook of liver disease. 5th ed. Philadelphia, PA: Saunders Elsevier 2006; 286.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21:1023-1032; quiz 1033-1034.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Yoo SM, Lee HY, Song IS, Lee JB, Kim GH, Byun JS. Acute hepatitis A: correlation of CT findings with clinical phase. Hepatogastroenterology. 2010;57:1208-1214.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452-1457.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 552]  [Cited by in F6Publishing: 577]  [Article Influence: 25.1]  [Reference Citation Analysis (0)]
5.  Mondelli MU, Cerino A, Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol. 2005;42 Suppl:S108-S114.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 53]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
6.  Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2003]  [Cited by in F6Publishing: 1928]  [Article Influence: 77.1]  [Reference Citation Analysis (0)]
7.  Mathiesen LR, Skinoj P, Nielsen JO, Purcell RH, Wong D, Ranek L. Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut. 1980;21:72-77.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 77]  [Cited by in F6Publishing: 80]  [Article Influence: 1.8]  [Reference Citation Analysis (1)]
8.  Gordon SC, Reddy KR, Schiff L, Schiff ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med. 1984;101:635-637.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol. 1986;146:1011-1015.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 143]  [Cited by in F6Publishing: 142]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
10.  Toppet V, Souayah H, Delplace O, Alard S, Moreau J, Levy J, Spehl M. Lymph node enlargement as a sign of acute hepatitis A in children. Pediatr Radiol. 1990;20:249-252.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 25]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
11.  Kurtz AB, Rubin CS, Cooper HS, Nisenbaum HL, Cole-Beuglet C, Medoff J, Goldberg BB. Ultrasound findings in hepatitis. Radiology. 1980;136:717-723.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Portincasa P, Moschetta A, Di Ciaula A, Palmieri VO, Milella M, Pastore G, Palasciano G. Changes of gallbladder and gastric dynamics in patients with acute hepatitis A. Eur J Clin Invest. 2001;31:617-622.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 22]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
13.  Kawamoto S, Soyer PA, Fishman EK, Bluemke DA. Nonneoplastic liver disease: evaluation with CT and MR imaging. Radiographics. 1998;18:827-848.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Zissin R, Osadchy A, Shapiro-Feinberg M, Gayer G. CT of a thickened-wall gall bladder. Br J Radiol. 2003;76:137-143.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 52]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
15.  Saini S. Imaging of the hepatobiliary tract. N Engl J Med. 1997;336:1889-1894.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 93]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
16.  Mortele KJ, Ros PR. Imaging of diffuse liver disease. Semin Liver Dis. 2001;21:195-212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 75]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
17.  Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR. 1995;16:16-33.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 72]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
18.  Han KS, Choi GB, Chang IJ, Lee SN, Kyung NH, Park LG. [Thickening of the gallbladder wall in acute viral hepatitis; ultrasonographic consideration]. Korean J Med. 1985;28:823-827.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Maudgal DP, Wansbrough-Jones MH, Joseph AE. Gallbladder abnormalities in acute infectious hepatitis. A prospective study. Dig Dis Sci. 1984;29:257-260.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 40]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
20.  Maresca G, De Gaetano AM, Mirk P, Cauda R, Federico G, Colagrande C. Sonographic patterns of the gallbladder in acute viral hepatitis. J Clin Ultrasound. 1984;12:141-146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 8]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
21.  van Breda Vriesman AC, Engelbrecht MR, Smithuis RH, Puylaert JB. Diffuse gallbladder wall thickening: differential diagnosis. AJR Am J Roentgenol. 2007;188:495-501.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 135]  [Cited by in F6Publishing: 145]  [Article Influence: 8.5]  [Reference Citation Analysis (0)]
22.  Jüttner HU, Ralls PW, Quinn MF, Jenney JM. Thickening of the gallbladder wall in acute hepatitis: ultrasound demonstration. Radiology. 1982;142:465-466.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Kim MY, Baik SK, Choi YJ, Park DH, Kim HS, Lee DK, Kwon SO. Endoscopic sonographic evaluation of the thickened gallbladder wall in patients with acute hepatitis. J Clin Ultrasound. 2003;31:245-249.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 15]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
24.  Suk KT, Kim CH, Baik SK, Kim MY, Park DH, Kim KH, Kim JW, Kim HS, Kwon SO, Lee DK. Gallbladder wall thickening in patients with acute hepatitis. J Clin Ultrasound. 2009;37:144-148.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 20]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
25.  Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6212]  [Cited by in F6Publishing: 5668]  [Article Influence: 333.4]  [Reference Citation Analysis (3)]
26.  Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499-505.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2528]  [Cited by in F6Publishing: 2551]  [Article Influence: 212.6]  [Reference Citation Analysis (1)]